Antigen preparations derived from a typical human strain of Vibrio fetus were employed in four tests. Of these, the indirect bacterial hemagglutination test proved most sensitive. By this test, antibodies titering 320 to 3,200 were found in five of eight patients with confirmed infections. Two patients without antibodies were on antimetabolites. Antigenic relationship with other compounds, and in particular with Brucella organisms, was not observed. No sero-reactors were found among 184 apparently healthy young men; of 401 unselected hospital patients, four had low sero-titers.
The incidence of Vibrio fetus infection in man is believed to be considerably higher than indicated by published case reports (5, 7, 18, 20) . It was estimated that less than 1% of the cases are recorded (1) . Several factors are involved: first, characteristic clinical symptoms are lacking (1); second, accurate timing of collection of blood cultures seems essential; and third, correct identification of V. fetus poses problems in laboratories unfamiliar with veterinary bacteriology. Diagnoses of the hitherto confirmed cases were established by the recovery of V. fetus from mono-infected tissues, usually blood. The organism has not been isolated from mixed flora of man.
Additional diagnostic tools are desirable. A standardized serological test is a possibility since many patients with generalized vibriosis possess high-titered humoral antibodies to the homologous bacterial strain (3, 5, 20) . Apart from the sensitivity and specificity of such a test, its usefulness would be determined mainly by the extent to which the employed antigen represents the antigenic determinants of V. fetus infecting man. Working with bovine and ovine strains of V. fetus, Morgan (10) allocated 18 strains to a somatic group A and 7 strains to group B. These findings were essentially confirmed by Soderlind (17) . King (6) found an even closer antigenic relationship among strains of V. fetus from man. Based on somatic antigens, however, Winkenwerden (21) and White and Walsh (19) classified human strains in two distinct serological groups. The somatic antigens were found to be soluble lipopolysaccharide complexes (2, 12, 13) . One such compound derived from V. fetus var. intestinalis consisted of 53% carbohydrates and 28% lipids (23) . The lipopolysaccharides were resistant to heat and alkali (2, 12) and readily adsorbed onto erythrocytes rendering them agglutinable by somatic antiserum (13, 23) . Addition of complement to erythrocytes coated with antigen-antibody complexes resulted in lysis (14) .
Flagellar antigens of both animal strains (8) and human strains (19) occur in numerous serotypes. K-antigens are irregular components of V. fetus (8) .
Thus, only the somatic antigen with its limited number of major determinants lends itself readily to the development of a serological test. This paper describes the results obtained with somatic antigen preparations from a typical human strain of V. fetus.
MATERIALS AND METHODS
Media. Thioglycolate broth (Baltimore Biological Laboratories) and Todd-Hewitt brotb (Difco) were employed according to the manufacturers' instructions. Chocolate-agar was prepared as follows: 43 g of Brucella agar (Pfizer Diagnostic Division) and 5 g of Pfizer agar (Pfizer Diagnostic Division) were dissolved in 1,000 ml of distilled water, autoclaved at 115 C for 15 min, and cooled to approximately 80 C. After the addition of 50 ml of citrated human blood, the mixture was cooled to 50 C and distributed into petri dishes (8.5 cm). Chocolate-agar prepared by the addition of 1% hemoglobin (Difco) to the base medium before autoclaving was equally effective.
Antigens. The following human V. fetus strains were used for antigen production: a strain recently isolated here from blood (St. Luke's strain); and for comparison, strains A3208 and A3430 (19) 1: 20. (ii) Heat-killed bacterial suspension: a sample of the bacterial suspension was heated to 100 C for 2 hr, washed twice in buffer, and resuspended in 0.5% Formalin in buffer.
(iii) Antigenic extract: unless otherwise stated, the bacterial suspension was heated to 100 C for 2 hr, cooled to room temperature, and centrifuged at 12,000 X g for 45 min. (iv) Ultrasonic treatment: a Branson sonifier model S125 operating at 20 kc was used for ultrasonic treatment of 10-ml amounts of bacterial suspension.
V. fetus rabbit antiserum. Albino rabbits (approximately 2.0 kg) were injected intravenously with a formalinized suspension of heated and washed V. fetus cells adjusted to ca. 109 organisms per ml. The antigen was administered four times, at 3-to 4-day intervals, in the following volumes: 1.0 ml, 1.0 ml, 2.0 ml, and 2.0 ml, respectively. The animals were bled 7 days after the last injection. High-titered sera were pooled, mixed with an equal volume of chemically pure glycerin, and stored at 4 C.
V. fetus sera from man. Sera, obtained from bacteriologically confirmed cases described in a previous paper (1) , were stored at -12 C.
Other antisera. Bacterial agglutination. Serum in serial twofold dilutions (0.25 ml) was mixed with an equal volume of bacterial suspension adjusted to ca. 109 organisms per ml. The mixture was incubated at 37 C for 18 hr, centrifuged at 500 X g for 3 min, and read.
Latex agglutination. Latex suspension (0.81 Mum, Difco) was diluted 1:50 in buffer and added to an equal volume of antigen solution. The mixture was incubated at 37 C for 30 min. To 0.5 ml of this reagent, antiserum in serial dilutions (0.5 ml) was added. The mixtures were incubated at 56 C for 90 min, centrifuged at 800 X g for 3 min, and examined for gross agglutination.
Indirect bacterial hemagglutination. The hemagglutination test (HA test) was carried out as described by Neter et al. (11) . Briefly, human type 0 erythrocytes (2.5% suspension) were washed three times in buffer. The sediment was resuspended to 2.5% in a dilution of antigen that would produce an HA titer of 1,600 to 3,200 against a glycerinated rabbit antiserum. The mixture was incubated at 37 C for 30 min; the modified erythrocytes were washed five times in excess buffer to remove unadsorbed antigen, and resuspended in buffer. The treated erythrocytes (0.2 ml) were mixed with twofold serially diluted antiserum (0.2 ml), and incubated at 37 C for 30 min. The resulting hemagglutination was read grossly after centrifugation at 800 X g for 3 min. Readings obtained with erythrocyte suspensions titering less than 1,600 or more than 3,200 with a glycerinated rabbit antiserum were discarded. All sera were examined a second time, and reactive sera were tested for agglutinins to uncoated erythrocytes.
RESULTS
Selection of indicator system. All four antigen preparations listed in Table 1 were titrated simultaneously against samples of a single set of serially diluted rabbit antiserum. The HA test was the most sensitive of the reactions examined; it was selected as our indicator system. Heated, washed bacterial cells gave clear-cut readings but were less sensitive. The employed antigenic extract did not lend itself readily to latex agglutination.
Antigen extraction. Regardless of the extraction method employed, NaOH hydrolysis was required to produce an antigenic solution capable of modifying the erythrocyte suspension to an HA titer of 1,600 to 3,200 against the glycerinated rabbit antiserum. Table 2 shows that heat treatment of the bacterial cells (boiling or autoclaving) produced the most suitable extracts for subse- Extraction of a heat-killed (80 C, 10 min) suspension of V. fetus with 0.02 N NaOH at 100 C for 5 min (22) failed to yield potent antigenic preparations. Regardless of the extraction method employed, centrifugation of the hydrolyzed extract at 20,000 X g for 45 min improved its modifying capacity.
Antigenic relationship to other strains. Glycerinated antisera were prepared to St. Luke's strain, A3208, and A3430. Cross-agglutination (Table 3) and absorption experiments with heated bacterial cells revealed that the somatic antigens of St. Luke's strain and strain A3208 were similar if not identical. There was no evidence of antigenic relationship between these strains and strain A3420.
Antibody levels in confirmed cases. Five of eight patients with confirmed V. fetus infections
(1) showed moderate to high HA-antibody titers at the time of bacteremia (Table 4) . Two of the patients without measurable antibody (Table 5) .
The HA test also failed to detect V. fetus antibodies among patients with moderate to high titers of humoral antibodies to: S. typhi, (10 patients); S. paratyphi A, (4 patients The high HA titers observed in most patients at the time of bacteremia declined significantly over a period of 4 to 6 months after clinical recovery. The low titers found in some hospital patients from whom V. fetus was not isolated may be attributed to: (i) prior infections; (ii) exposure to similar antigens from sources other than V. fetus; (iii) localized intestinal infection with V. fetus var. intestinalis; or (iv) "natural antibodies" (22) . Antigenic relationship between V. fetus and Brucella organisms was claimed by Spink (18 (9) , White (19) 
